
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. (CNSP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CNSP · as of Jun 8, 2026
Key Statistics
Explore CNS Pharmaceuticals, Inc. Data
cnsp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The CNSP analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $0.50, representing -89.85% downside from the current price of $4.92.
Competitors & Peers
cnsp competitorsStock Performance
Full HistoryAbout CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead…
what is cns pharmaceuticals, inc. · cnsp stock overview · cns pharmaceuticals, inc. company profile · who is cns pharmaceuticals, inc. ceo · cnsp NASDAQ · cns pharmaceuticals, inc. headquarters · cns pharmaceuticals, inc. business segments
About Stock Overview & Key Data
CNS Pharmaceuticals, Inc. (CNSP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 8, 2019. As of the latest trading session, CNSP stock price is $4.92, with a market capitalization of $2.8M. The stock has returned -59.51% over the past 12 months and -4.67% year-to-date.
According to 4 Wall Street analysts, the consensus rating for CNS Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $0.50. In fiscal year 2025, CNS Pharmaceuticals, Inc. reported revenue of — and net income of -$15.9M. For detailed data — including CNS Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, CNS Pharmaceuticals, Inc. (CNSP) stock price is $4.92. The stock is traded on NASDAQ under the ticker symbol CNSP. The 52-week range is $1.90 – $12.84.